CAPTRUST Financial Advisors
ITCI

CAPTRUST Financial Advisors’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

CAPTRUST Financial Advisors’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-5,234
Closed -$690K – 2608
2025
Q1 		$690K Sell
5,234
-4,422
-46% -$551K ﹤0.01% 1467
2024
Q4 		$806K Buy
9,656
+1,606
+20% +$132K ﹤0.01% 1350
2024
Q3 		$589K Buy
8,050
+2,572
+47% +$193K ﹤0.01% 1484
2024
Q2 		$375K Sell
5,478
-1,239
-18% -$85.9K ﹤0.01% 1670
2024
Q1 		$465K Sell
6,717
-13,210
-66% -$908K ﹤0.01% 1522
2023
Q4 		$1.43M Sell
19,927
-6,795
-25% -$391K ﹤0.01% 1069
2023
Q3 		$1.39M Buy
26,722
+7,942
+42% +$463K 0.01% 1010
2023
Q2 		$1.19M Buy
18,780
+13,075
+229% +$815K ﹤0.01% 1106
2023
Q1 		$309K Sell
5,705
-53
-0.9% -$2.56K ﹤0.01% 1725
2022
Q4 		$305K Buy
+5,758
New +$289K ﹤0.01% 1642
2022
Q3 		– Sell
-984
Closed -$56K – 4193
2022
Q2 		$56K Sell
984
-21
-2% -$1.19K ﹤0.01% 2660
2022
Q1 		$61K Buy
1,005
+99
+11% +$5.14K ﹤0.01% 2654
2021
Q4 		$47K Buy
906
+231
+34% +$9.7K ﹤0.01% 2727
2021
Q3 		$25K Buy
675
+90
+15% +$3.13K ﹤0.01% 3024
2021
Q2 		$24K Hold
585
– – ﹤0.01% 2985
2021
Q1 		$20K Buy
585
+285
+95% +$9.89K ﹤0.01% 3010
2020
Q4 		$10K Hold
300
– – ﹤0.01% 2580
2020
Q3 		$8K Hold
300
– – ﹤0.01% 2385
2020
Q2 		$8K Buy
+300
New +$6.07K ﹤0.01% 2277

Other funds holding ITCI

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
KIM
Kestra Investment Management Austin, Texas $5.8B AUM 14.71% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

CAPTRUST Financial Advisors's ITCI Position: Q2 2025 in Review

CAPTRUST Financial Advisors sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 5,234 shares — an estimated $690K sold.

CAPTRUST Financial Advisors first reported a position in ITCI in Q2 2020 and held it in 19 quarters. The position peaked at $1.43M in Q4 2023. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

  • CAPTRUST Financial Advisors reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 5,234 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $690K.
  • CAPTRUST Financial Advisors first reported a position in Intra-Cellular Therapies Inc. in Q2 2020 and held it in 19 quarters.
  • CAPTRUST Financial Advisors's Intra-Cellular Therapies Inc. position peaked at $1.43M in Q4 2023.
  • 4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on CAPTRUST Financial Advisors's 13F filing for Q2 2025, filed 15 Aug 2025.